Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 21st February 2013
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Possible Schmallenberg vaccine confirmed
VMD provides information on MSD application

After renewed calls from the farming industry the Veterinary Medicines Directive (VMD) has released information regarding a possible vaccine for Schmallenberg.

The directorate has taken the unusual step of sharing information regarding the MSD's application for its 'Bovilis SBV' vaccine. Usually the directorate is unable to comment on any applications it has received, or their current status, for reasons of commercial confidentiality. However in light of the media interest surrounding the possible vaccine, MSD has allowed the VMD to release certain information.

The VMD has confirmed it received an application for a provisional marketing authorisation at the end of August 2012. The application was then completed and validated in mid September 2012 following the provision of further data.

According to the directorate the initial assessment was completed, and further enquiries were sent to the company in question towards the end of November 2012. After receiving a response at the end of January 2013, the VMD are now assessing this information.

A VMD spokesman said: "Despite the good progress, at this stage it is not possible to provide an indication of when the vaccine may be authorised.



"The VMD recognises the impact on individual animals and farmers a disease such as Schmallenberg can have.

"The VMD will operate timelines for the remaining stages of consideration of the application mindful of this while ensuring, through our rigorous scientific assessment process, that proper care is taken to ensure that any vaccine is safe for the relevant livestock."

Become a member or log in to add this story to your CPD history

Webinar to explore history of KC breed registers

News Story 1
 A free webinar exploring the development of the Kennel Club's registration system and the evolution of closed breed registers has been announced.

Hosted by Dr Alison Skipper, veterinary and research advisor at the Kennel Club, the webinar will delve into the development of the registry and how the changing landscape of scientific knowledge has shaped breeding practices. It will also look at what this means for the future of pedigree dogs.

The session will culminate with a look at The Kennel Club's ongoing and future engagement in this area, with a chance for attendees to put forward their thoughts and questions for discussion.

This event takes place on Microsoft Teams on Tuesday, 10 June at 7pm. To learn more, visit events.teams.microsoft.com  

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.